We spent the weekend at the huge American Diabetes Association annual Scientific Sessions event in Chicago. Everybody who’s anybody in D was there — except Abbott and Bayer, who opted out of exhibiting this year ostensibly due to the hit that the blood glucose monitoring market is taking in the face of reimbursement overhaul.
By the numbers:
Upwards of 17,730 people attending overall (Monday morning’s count)
14,570 scientists, physicians, and other HCPs
2,500 abstracts (papers…